Cargando…

Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine

Peripheral T-cell lymphoma (PTCL) is a rare, heterogenous group of mature T-cell neoplasms that comprise 10–15% of non-Hodgkin lymphoma cases in the United States. All subtypes of PTCL, except for ALK(+) anaplastic T-cell lymphoma, are associated with poor prognosis, with median overall survival (OS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yumeng, Lee, Dasom, Brimer, Thomas, Hussaini, Mohammad, Sokol, Lubomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317006/ https://www.ncbi.nlm.nih.gov/pubmed/32637355 http://dx.doi.org/10.3389/fonc.2020.00898

Ejemplares similares

Transformation of T-Cell Acute Lymphoblastic Lymphoma to Peripheral T-Cell Lymphoma: A Report of Two Cases
por: Markow, Michael, et al.
Publicado: (2018)

New Insights Into the Complex Mutational Landscape of Sézary Syndrome
por: Mirza, Abu-Sayeef, et al.
Publicado: (2020)

Phenytoin-Associated Lymphoadenopathy Mimicking a Peripheral T-cell Lymphoma
por: Johns, Mark E., et al.
Publicado: (2010)

Prediction of Cancer Drug Resistance and Implications for Personalized Medicine
por: Volm, Manfred, et al.
Publicado: (2015)

Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL)
por: Sokol, Kelsey, et al.
Publicado: (2019)

Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma
por: Kim, Tong-Yoon, et al.
Publicado: (2022)

Tyrosine kinases in nodal peripheral T-cell lymphomas
por: Piccaluga, Pier Paolo, et al.
Publicado: (2023)

Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T‐cell lymphoma
por: Foss, Francine, et al.
Publicado: (2016)

Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Zhang, Yumeng, et al.
Publicado: (2022)

Peripheral T-Cell Lymphomas: A Review of Current Approaches and Hopes for the Future
por: Skarbnik, Alan P., et al.
Publicado: (2013)

Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis
por: Fragliasso, Valentina, et al.
Publicado: (2021)

Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study
por: Liu, Shuo, et al.
Publicado: (2022)

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry
por: Mocikova, Heidi, et al.
Publicado: (2022)

Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability
por: Zain, Jasmine, et al.
Publicado: (2023)

The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment
por: Gong, Lanqi, et al.
Publicado: (2021)

Circulating Tumor Cells: The Substrate of Personalized Medicine?
por: Greene, Bryan T., et al.
Publicado: (2012)

Precision Medicine in Lymphoma by Innovative Instrumental Platforms
por: Di Paolo, Antonello, et al.
Publicado: (2019)

Skin-first nodulotumoral adult T-cell lymphoma mimicking cutaneous T-cell lymphoma
por: Cohen, Leah, et al.
Publicado: (2019)

Long-Term Remission After Matched Sibling Donor Hematopoietic Cell Transplantation in a Patient With Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
por: Gesiotto, Quinto, et al.
Publicado: (2021)

Hepatitis B Reactivation in the Treatment of Non-Hodgkin Lymphoma
por: Kelling, Matthew, et al.
Publicado: (2018)

Chemotherapy Plus Radiotherapy Versus Chemotherapy Alone for Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified
por: Chen, Zegeng, et al.
Publicado: (2021)

Classification and challenges in the histopathological diagnosis of peripheral T-cell lymphomas, emphasis on the WHO-HAEM5 updates
por: Murga-Zamalloa, Carlos, et al.
Publicado: (2022)

Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
por: Foss, Francine, et al.
Publicado: (2016)

All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma
por: Fante, Matthias A., et al.
Publicado: (2023)

Erratum to: Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial
por: Foss, Francine, et al.
Publicado: (2017)

Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
por: Kim, Seok Jin, et al.
Publicado: (2023)

Hepatic Infiltration with Malignant T-cells Manifesting as Impending Acute Liver Failure in Sezary Syndrome
por: Zhang, Yumeng, et al.
Publicado: (2020)

“Alterations in the Skin Microbiota Are Associated With Symptom Severity in Mycosis Fungoides”
por: Zhang, Yumeng, et al.
Publicado: (2022)

Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma
por: Wang, Huan-You, et al.
Publicado: (2021)

Increased Serum Level of Interleukin-10 Predicts Poor Survival and Early Recurrence in Patients With Peripheral T-Cell Lymphomas
por: Zhang, Yan, et al.
Publicado: (2020)

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
por: Liu, Weiping, et al.
Publicado: (2021)

Artificial Intelligence in the Management of Glioma: Era of Personalized Medicine
por: Sotoudeh, Houman, et al.
Publicado: (2019)

Limitations of Personalized Medicine and Gene Assays for Breast Cancer
por: Tiberi, David, et al.
Publicado: (2017)

Hepatitis B Reactivation with Novel Agents in Non-Hodgkin’s Lymphoma and Prevention Strategies
por: Ozoya, Oluwatobi O., et al.
Publicado: (2016)

The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas
por: Tomacinschii, Victor, et al.
Publicado: (2023)

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis
por: Gao, Hongye, et al.
Publicado: (2022)

Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment
por: Helgadottir, Hildur, et al.
Publicado: (2018)

Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?
por: Fidelito, Gio, et al.
Publicado: (2022)

Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism
por: Gunter, Jennifer H., et al.
Publicado: (2022)

A phase I dose-escalation study of neoantigen-activated haploidentical T cell therapy for the treatment of relapsed or refractory peripheral T-cell lymphoma
por: Chen, Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_robrri24h2gegntdl02at8gph8